News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Jeanne Linke Northrop

Advertisement

Articles by Jeanne Linke Northrop

Dave Bearss, PhD, CEO, Halia Therapeutics Image courtesy of Halia Therapeutics

Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

ByJeanne Linke Northrop
June 13th 2024

Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.

Advertisement

Latest Updated Articles

  • Dave Bearss, PhD, CEO, Halia Therapeutics Image courtesy of Halia Therapeutics
    Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

    June 13th 2024



Advertisement
Advertisement

Trending on PharmExec

1

Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal

2

Marty Makary Out as FDA Commissioner: Report

3

The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff

4

From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box

5

Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us